Compare AMRX & CACC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AMRX | CACC |
|---|---|---|
| Founded | 2002 | 1972 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.8B | 6.5B |
| IPO Year | 2018 | 1996 |
| Metric | AMRX | CACC |
|---|---|---|
| Price | $18.05 | $618.86 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 2 |
| Target Price | $15.60 | ★ $505.00 |
| AVG Volume (30 Days) | ★ 2.1M | 177.8K |
| Earning Date | 05-01-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 157.89 | 83.00 |
| EPS | 0.19 | ★ 12.40 |
| Revenue | N/A | ★ $2,317,200,000.00 |
| Revenue This Year | $4.48 | $91.73 |
| Revenue Next Year | $7.13 | $3.58 |
| P/E Ratio | $92.18 | ★ $49.66 |
| Revenue Growth | N/A | ★ 7.16 |
| 52 Week Low | $7.67 | $401.90 |
| 52 Week High | $18.39 | $668.86 |
| Indicator | AMRX | CACC |
|---|---|---|
| Relative Strength Index (RSI) | 67.85 | 52.68 |
| Support Level | $12.46 | $529.10 |
| Resistance Level | N/A | $668.86 |
| Average True Range (ATR) | 0.59 | 21.39 |
| MACD | -0.05 | -4.84 |
| Stochastic Oscillator | 80.15 | 25.98 |
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.
Credit Acceptance Corp is a consumer finance company that specializes in automobile loans. These loans are offered through a U.S. nationwide network of automobile dealers that benefit from sales of vehicles to consumers who could otherwise not obtain financing. The company also benefits from repeat and referral sales, and from sales to customers responding to advertisements for financing, but qualify for traditional financing. The company derives its revenue from finance charges, premiums earned on the reinsurance of vehicle service contracts, and other fees. Of these, financing charges, including servicing fees, are by far a source of revenue.